Design and Prototyping of a Smart Medicare Diabetic Shoe - Phase II

智能医疗糖尿病鞋的设计和原型制作 - 第二阶段

• 批准号: 560397-2020
• 负责人: Potter, Simon
• 金额: $ 5.46万
• 依托单位: Red River College Polytechnic
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 2
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=723881
• 关键词: Design; Prototyping; Smart; Medicare; Diabetic

Avriel International, based in Canada, is a growing specialty footwear manufacturing company that producesvarieties of orthotic, diabetic and dancing shoes. In an effort to expand their product offerings, Avriel isdeveloping a Medicare Diabetic Shoe with embedded sensors that will improve patients' awareness ofdiminished sensations in their feet. The sensors will give an alarm notification and valuable data to the patientand clinicians when data being logged is outside a "safe" zone. The innovative technology is expected toimprove patients' ability to manage chronic conditions and avoid amputation that could result fromunawareness of impending dangers. Avriel would like to implement this technology as intelligent insoles thatcan be used with any shoe.Initially, Avriel worked on this innovation with the University of Manitoba to perform fundamental researchstudy, in which basic electronics and sensors were integrated and tested with a shoe. This initial researchprovided useful information on the "Smart Shoe" concept. The developed solution was quite basic, with theelectronics and sensors lacking the small-scale requirement for integration into an insole as a prototype. As afirst step towards commercialization of the innovation, Avriel collaborated with us at the Technology AccessCentre for Aerospace and Manufacturing (TACAM) at Red River College (RRC), through an NSERC EngageGrant, to design, develop and implement a completely integrated smart insole prototype. The first phase of theproject met all the objectives with a smart insole prototype successfully developed. Avriel intends on buildingon this previous success, in this proposed Phase II, by progressing the Technology Readiness Level (TRL) ofthe product and bring it to pre-commercialization.This second phase is aimed at improving the manufacturability of the integrated insole, expanding therobustness and reliability of the product, as well as to refine the user experience. Flexible circuits board willreplace the current rigid circuit boards, the insole materials will be remanufactured for comfort, and the current

Avriel International 总部位于加拿大，是一家成长中的专业鞋类制造公司，生产各种矫形鞋、糖尿病鞋和舞鞋。为了扩大产品范围，Avriel 正在开发一款带有嵌入式传感器的 Medicare 糖尿病鞋，该鞋将提高患者对脚部感觉减弱的认识。当记录的数据超出“安全”区域时，传感器将向患者和临床医生发出警报通知和有价值的数据。这项创新技术预计将提高患者管理慢性病的能力，并避免因不了解即将发生的危险而导致截肢。 Avriel 希望将这项技术实现为可用于任何鞋子的智能鞋垫。最初，Avriel 与曼尼托巴大学合作进行这项创新，进行基础研究，其中将基本电子设备和传感器与鞋子集成并进行测试。这项初步研究提供了有关“智能鞋”概念的有用信息。开发的解决方案非常基础，电子设备和传感器缺乏集成到鞋垫中作为原型的小规模要求。作为创新商业化的第一步，Avriel 通过 NSERC EngageGrant 与我们在红河学院 (RRC) 航空航天和制造技术访问中心 (TACAM) 合作，设计、开发和实施完全集成的智能鞋垫原型。该项目第一阶段实现了所有目标，成功开发了智能鞋垫原型。 Avriel 打算在先前的成功基础上，在拟议的第二阶段中，提高产品的技术成熟度 (TRL) 并将其推向预商业化。第二阶段的目标是提高集成鞋垫的可制造性，扩大产品的耐用性和可靠性，并改善用户体验。柔性电路板将取代目前的刚性电路板，鞋垫材料将重新制造以提高舒适度，目前的